Search

Author/Creator Harris, Christopher M.

1. ABBV-105, a selective and irreversible inhibitor of Bruton's tyrosine kinase, is efficacious in multiple preclinical models of inflammation. Issue 3 (4th May 2019)

Authors:
Goess, Christian; Harris, Christopher M.; Murdock, Sara; McCarthy, Richard W.; Sampson, Erik; Twomey, Rachel; Mathieu, Suzanne; Mario, Regina; Perham, Matthew; Goedken, Eric R.; Long, Andrew J.
Journal:
Modern rheumatology
Issue:
Volume 29:Issue 3(2019)
Page Start:
510
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Creation of a S1P Lyase bacterial surrogate for structure-based drug design. Issue 9 (1st May 2016)

Authors:
Argiriadi, Maria A.; Banach, David; Radziejewska, Elzbieta; Marchie, Susan; DiMauro, Jennifer; Dinges, Jurgen; Dominguez, Eric; Hutchins, Charles; Judge, Russell A.; Queeney, Kara; Wallace, Grier; Harris, Christopher M.
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 26:Issue 9(2016)
Page Start:
2293
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. DT‐01‐05: THE USE OF SELECTIVE SPHINGOSINE‐1‐PHOSPHATE RECEPTOR 5 AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS SUCH AS ALZHEIMER'S DISEASE AND LYSOSOMAL STORAGE DISEASES SUCH AS NIEMANN‐PICK C DISEASE. (1st July 2014)

Authors:
van der Kam, Elizabeth; Turner, Sean; van Bergeijk, Jeroen; Mueller, Reinhold; Mezler, Mario; Bespalov, Anton; Hobson, Adrian; Harris, Christopher M.; Rendenbach‐Mueller, Beatrice; Schoemaker, Hans
Journal:
Alzheimer's & dementia
Issue:
Volume 10:Supplement 4S(2014)Part 16
Page Start:
P281
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗